This prospective, phase IV study used an integrated genomic analysis to identify markers associated with 1-month change in IGF-I (IGF-I) following initiation of recombinant human (r-h)GH therapy in treatment-nave children with GH deficiency (GHD) ( n =166) or Turner syndrome (TS) ( n =147)
To acquire more information about the mitochondrial function of Gclc -deficient FoB, we investigated mitochondrial size and conformation
[4] Common neurotransmitters include glutamate, GABA, acetylcholine, glycine, dopamine and norepinephrine
Supported with expert medical team supervision
Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF